Ling Shi Tan
Amministratore Delegato presso dMed Biopharmaceutical Technology (Shanghai) Co., Ltd.
Profilo
Ling Shi Tan is the founder of dMed Biopharmaceutical Technology (Shanghai) Co., Ltd., where he currently holds the title of Chairman & Chief Executive Officer.
He also founded dMedClinical Co. Ltd.
in 2021 and serves as the Global Chairman & Chief Executive Officer.
Prior to his founding positions, Dr. Tan was the Chairman of the Drug Information Association.
Posizioni attive di Ling Shi Tan
| Società | Posizione | Inizio |
|---|---|---|
dMed Biopharmaceutical Technology (Shanghai) Co., Ltd.
 dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology DMed Biopharmaceutical Technology Shanghai Co., Ltd. engages in the development of medicines and medical devices. The company was founded by Ling Shi Tan on August 3, 2016 and is headquartered in Shanghai, China. | Amministratore Delegato | - |
dMedClinical Co., Ltd.
 dMedClinical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services dMedClinical Co. Ltd., formerly known as Caidya, is a leading clinical research organization that offers medical writing services for clinical trials. The company is based in Shanghai, CN, and has subsidiaries in Germany, Switzerland, United States, United Kingdom, and China. The Chinese company uses a combination of industry-recognized, proprietary, and third-party technologies to ensure transparency and cost efficiency in clinical trials. The company specializes in infectious disease clinical trial services and provide expertise for therapeutic developments. dMedClinical Co. was founded in 2021 by Ling Shi Tan, who has been the CEO since then. | Amministratore Delegato | 01/04/2021 |
Precedenti posizioni note di Ling Shi Tan
| Società | Posizione | Fine |
|---|---|---|
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Presidente | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
dMed Biopharmaceutical Technology (Shanghai) Co., Ltd.
dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology DMed Biopharmaceutical Technology Shanghai Co., Ltd. engages in the development of medicines and medical devices. The company was founded by Ling Shi Tan on August 3, 2016 and is headquartered in Shanghai, China. | Health Technology |
dMedClinical Co., Ltd.
dMedClinical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services dMedClinical Co. Ltd., formerly known as Caidya, is a leading clinical research organization that offers medical writing services for clinical trials. The company is based in Shanghai, CN, and has subsidiaries in Germany, Switzerland, United States, United Kingdom, and China. The Chinese company uses a combination of industry-recognized, proprietary, and third-party technologies to ensure transparency and cost efficiency in clinical trials. The company specializes in infectious disease clinical trial services and provide expertise for therapeutic developments. dMedClinical Co. was founded in 2021 by Ling Shi Tan, who has been the CEO since then. | Commercial Services |
- Borsa valori
- Insiders
- Ling Shi Tan
